MODASMART 400

What is MODASMART 400?

MODASMART 400 is a modern pharmaceutical product belonging to the group of nootropic agents and central nervous system stimulants of indirect action. Its primary purpose is to maintain an active wakeful state, eliminate excessive daytime sleepiness, and improve cognitive functions in patients with relevant disorders. The drug is manufactured in the form of tablets for oral administration, which ensures ease of intake and accurate dosing. The manufacturer of MODASMART 400 is the Indian pharmaceutical company Winlife Pharma, known for its high-quality products in the ASSURANS, CENFORCE, and MALEGRA categories. This medication belongs to the prescription category; therefore, its use requires prior consultation with a physician and a thorough medical examination.

The pharmacological activity of MODASMART 400 is due to its ability to influence the neurotransmitter systems of the brain, particularly the metabolism of dopamine, norepinephrine, and histamine. Unlike classic amphetamine-type psychostimulants, the drug has a significantly lower potential for addiction development and less pronounced peripheral sympathomimetic effects. This makes its safety profile more favorable for long-term use under specialist supervision. The therapeutic effect develops gradually, reaching peak plasma concentration 2–4 hours after ingestion. The duration of action is usually from 12 to 15 hours, allowing for high performance levels throughout the day without the need for repeated administration.

Winlife Pharma applies modern quality control standards at all stages of MODASMART 400 production, guaranteeing the stability of the pharmacological properties of every batch. The drug has undergone the necessary clinical trials and is registered for medical use in many countries worldwide. It is important to understand that MODASMART 400 is not a means for self-medication or for increasing mental performance in healthy individuals without medical indications. Its use must be strictly justified and correspond to medical recommendations. Uncontrolled intake can lead to adverse consequences; therefore, self-prescription is strictly not recommended.

What is MODASMART 400 prescribed for?

The main indications for the use of MODASMART 400 are conditions accompanied by pathological daytime sleepiness and sleep-wake cycle disruption. Most often, the drug is prescribed to patients diagnosed with narcolepsy — a chronic neurological disorder in which the brain cannot properly regulate sleep cycles. In such patients, MODASMART 400 helps reduce the frequency of sudden sleep attacks and increase overall daytime activity levels. The drug is also effective for obstructive sleep apnea syndrome, when night sleep is interrupted by frequent breathing pauses, leading to chronic fatigue and daytime sleepiness. In these cases, MODASMART 400 is used as an adjunctive therapy alongside main treatments aimed at addressing the cause of the apnea.

Another important indication is shift work sleep disorder, which occurs in people working shift hours or night shifts. Disruption of natural biorhythms leads to marked sleepiness during work hours and insomnia during the day, significantly reducing the quality of life and increasing the risk of occupational errors. MODASMART 400 helps adapt the body to an unconventional schedule while maintaining the necessary level of attention and concentration during wakefulness. In certain clinical situations, the drug may be recommended for chronic fatigue syndrome or idiopathic hypersomnia, although such use requires careful justification. The physician evaluates the benefit-risk ratio for each patient individually.

It is worth emphasizing that MODASMART 400 is not intended for treating ordinary fatigue caused by lack of sleep or overwork in healthy people. Its use to boost productivity without medical indications is dangerous and not recommended. The drug acts on neurotransmitter systems that regulate fundamental sleep and wakefulness processes, so unnecessary interference can disrupt the body's natural self-regulation mechanisms. Only a qualified specialist can determine the appropriateness of prescribing MODASMART 400 after a full clinical evaluation and an accurate diagnosis. Self-medication with this drug can lead to serious sleep and mental health disturbances.

Composition and active ingredients of MODASMART 400

The main active ingredient of MODASMART 400 is modafinil at a dosage of 400 mg per single tablet. Modafinil is a synthetic compound belonging to the benzhydrylsulfinylacetamide class, possessing a unique mechanism of action that sets it apart from traditional psychostimulants. It selectively affects specific areas of the hypothalamus, particularly neurons that produce orexin (hypocretin) — a neuropeptide responsible for maintaining wakefulness. Modafinil increases the extracellular concentration of dopamine by blocking its reuptake, but does so more gently and selectively than amphetamines. This mechanism provides a pronounced wake-promoting effect without significant excitation of the sympathetic nervous system.

Excipients in MODASMART 400 act as fillers, binders, and stabilizers, ensuring proper pharmacokinetics and preservation of the active substance's efficacy. These include microcrystalline cellulose, starch, magnesium stearate, and other pharmaceutically inert compounds. These components do not have an independent pharmacological effect, but guarantee uniform release of modafinil in the gastrointestinal tract. Winlife Pharma's manufacturing technology involves strict purity control and compliance of all ingredients with international quality standards. This is especially important for medications affecting the central nervous system, where even minor compositional variations can alter the therapeutic profile.

In addition to affecting the dopamine system, modafinil in MODASMART 400 modulates the activity of histamine, norepinephrine, and glutamate receptors. This leads to increased attention levels, improved concentration, and the ability to perform prolonged mental work without a sense of exhaustion. It is important to note that the drug does not cause euphoria and has no marked abuse potential, as confirmed by numerous clinical studies. However, individual bodily responses may vary, so initial doses are recommended under medical supervision. This allows for timely detection of possible adverse effects and dosage adjustment.

Dosage of MODASMART 400

The standard recommended dose of MODASMART 400 for adult patients is 200 mg once daily; however, in some cases, a physician may prescribe 400 mg, especially with an inadequate response to the lower dose. The drug is taken in the morning to avoid disrupting nighttime sleep, as modafinil's duration of action can reach up to 15 hours. For patients with shift work sleep disorder, the dosage can be adapted: the tablet is taken 1 hour before the start of the work shift. The maximum daily dose should not exceed 400 mg, as further increases do not enhance the therapeutic effect but raise the risk of adverse reactions.

The duration of the treatment course with MODASMART 400 is determined individually, depending on the diagnosis and the patient's response to therapy. In narcolepsy and sleep apnea, the drug can be used long-term, but with periodic evaluation of efficacy and the necessity of continuing treatment. For patients with shift work sleep disorder, the course is usually limited to the schedule adaptation period. Elderly patients and individuals with impaired liver function may require a reduced dosage. Abrupt discontinuation of MODASMART 400 usually does not cause a severe withdrawal syndrome, but a gradual reduction of the dose is more physiological.

It is crucial to strictly adhere to the dosing regimen prescribed by your doctor and not to modify it independently. An overdose of MODASMART 400 can manifest as severe agitation, anxiety, tachycardia, elevated blood pressure, and insomnia. In such cases, immediate medical attention is required to conduct symptomatic therapy. Patients with cardiovascular diseases are recommended to undergo a full cardiological evaluation before starting the medication. MODASMART 400 is not intended for use in children and adolescents under 18 years of age due to the lack of sufficient safety data in this age group.

How to take MODASMART 400 correctly?

MODASMART 400 is taken orally with a sufficient amount of water, regardless of food intake. However, it should be noted that fatty food can delay the absorption of the drug and postpone the onset of the therapeutic effect by 1–2 hours. To achieve a stable blood concentration, it is recommended to take the tablet at the same time every day. If a patient forgets to take the drug in the morning, they should do so as soon as they remember, but no later than noon. Taking MODASMART 400 in the afternoon may cause significant difficulty falling asleep and disrupt the natural sleep cycle.

During treatment with MODASMART 400, it is recommended to avoid alcohol consumption, as ethanol can enhance central nervous system side effects and reduce the effectiveness of therapy. Patients should refrain from driving vehicles and operating complex machinery until they determine their individual reaction to the medication. Although MODASMART 400 usually improves concentration, in some individuals it can cause dizziness or excessive agitation, which negatively affects the ability to drive safely. It is also important to maintain a regular sleep schedule, as the drug does not replace full night rest.

If a regular dose is missed, do not double the next dose to compensate for the forgotten one. This can lead to an overdose and the development of adverse reactions. If a patient plans to stop taking MODASMART 400, it is recommended to discuss this with a doctor to determine the optimal withdrawal scheme. In most cases, the drug can be discontinued at once, but with prolonged use at high doses, a gradual reduction may be required. The individual response to modafinil can vary, so it is important to report any unusual symptoms to your doctor during treatment.

Side effects of MODASMART 400

The most common side effects of MODASMART 400 are headache, nervousness, anxiety, and insomnia, especially if the drug is taken too late in the day. These symptoms usually occur at the start of treatment and lessen as the body adapts. Patients may also report dry mouth, nausea, loss of appetite, and dyspeptic disorders. From the cardiovascular system, tachycardia, palpitations, and a slight increase in blood pressure are possible. Most of these reactions are transient and do not require drug discontinuation; however, they should be reported to a doctor.

Less common but more serious side effects of MODASMART 400 include psychiatric disorders such as depression, hallucinations, manic episodes, and suicidal thoughts. Patients with a history of psychiatric conditions require special attention, as modafinil can trigger the exacerbation of latent mental illnesses. Rare but potentially dangerous are severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. If a rash, blisters, swelling of the face, or mucous membranes appear, stop taking the medication immediately and seek emergency medical help.

Patients should be aware that MODASMART 400 can reduce the efficacy of hormonal contraceptives, so women of childbearing potential are recommended to use additional contraceptive methods. An individual's reaction to the drug can be unpredictable, so if any alarming symptoms occur, consult a physician. Regular medical monitoring during treatment allows for the timely detection of unwanted effects and adjustment of therapy. Do not ignore even seemingly minor changes in well-being, as they can be early signs of serious complications.

Contraindications of MODASMART 400

Absolute contraindications to the use of MODASMART 400 include hypersensitivity to modafinil or any auxiliary component of the drug. The medication is not prescribed to patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, arrhythmias, ischemic heart disease, and recent myocardial infarction. The presence of pronounced anxiety, psychomotor agitation, or psychotic disorders is also a contraindication, as modafinil can aggravate these conditions. For patients with liver cirrhosis or severe hepatic impairment, the drug is contraindicated due to altered metabolism of the active substance.

Pregnancy and breastfeeding are absolute contraindications to taking MODASMART 400. Animal studies have shown potential risk to the fetus, and human safety data are insufficient. Women of childbearing potential are recommended to rule out pregnancy before starting treatment and use reliable methods of contraception during therapy. The drug is not prescribed to children and adolescents under 18 years of age due to the lack of clinical data on efficacy and safety in this age group. In elderly patients, MODASMART 400 is prescribed with caution, often in reduced doses, due to an increased risk of side effects.

Relative contraindications include a history of psychiatric illness, epilepsy, renal impairment, and substance abuse. In such cases, the decision to prescribe MODASMART 400 is made by a physician after a careful assessment of the benefit-risk ratio. Patients with these conditions may require more frequent monitoring and dose adjustment. Before starting treatment, it is necessary to inform your doctor about all existing diseases and medications taken, including over-the-counter drugs and dietary supplements. This will help avoid dangerous drug interactions and minimize the risk of complications.

Interaction of MODASMART 400 with other drugs and alcohol

MODASMART 400 can interact with a number of medications, altering their efficacy or increasing the risk of side effects. Simultaneous use with hormonal contraceptives requires special attention, as modafinil induces liver enzymes, leading to a decrease in their blood concentration and reduced contraceptive effect. The drug may also enhance the action of anticoagulants such as warfarin, requiring regular monitoring of blood clotting parameters. Co-administration with antidepressants, especially MAO inhibitors, tricyclic antidepressants, and selective serotonin reuptake inhibitors, requires caution due to the risk of developing serotonin syndrome.

Alcohol consumption during treatment with MODASMART 400 is strictly not recommended. Ethanol can worsen central nervous system side effects such as dizziness, impaired coordination, and drowsiness, as well as increase the risk of developing mental disorders. In addition, alcohol can negate the therapeutic effect of the drug, leading to the return of primary disease symptoms. Patients taking MODASMART 400 should exercise caution when driving vehicles and operating machinery, especially at the beginning of treatment until their individual response to the drug is established. Any doubts regarding drug compatibility should be discussed with a doctor or pharmacist.

Where to buy MODASMART 400 in Ukraine

MODASMART 400 is a prescription drug, so its purchase is possible only with an appropriate prescription from a doctor. In Ukraine, the drug is available in many licensed pharmacies, as well as through certified online platforms specializing in the delivery of medicines. When purchasing, it is important to check the integrity of the packaging, expiration date, and protective elements confirming the originality of Winlife Pharma products. MODASMART 400 should be stored in a dry, light-protected place at a temperature not exceeding 25 degrees Celsius, out of the reach of children.

Before buying MODASMART 400, it is recommended to compare conditions across different pharmacy chains and online services, paying attention to licensing and the option to consult a pharmacist. Do not buy the drug from dubious sellers or unverified websites, as there is a risk of receiving a counterfeit or low-quality product. Remember that self-medication with MODASMART 400 can be dangerous to your health, so consult a qualified doctor before use. Only a specialist can determine the appropriateness of prescribing the drug and select the optimal dosage taking into account individual body characteristics.